Choline PET/CT and MRI for Targeted Prostate Biopsy

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Prostate Cancer
Interventions
PROCEDURE

Prostate Cancer Imaging

After imaging is completed, subjects will be scheduled for a prostate biopsy performed as part of their clinical care. If the imaging has identified suspicious lesions in the prostate, these regions will be made visible for the Urologist to be targeted for additional biopsies. These additional biopsies will undergo histological evaluation and further metabolomic testing to better understand metabolic differences between various grades of prostate cancer lesions.

Trial Locations (1)

48109

University of Michigan Health Systems, Ann Arbor

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Michigan

OTHER

NCT01751737 - Choline PET/CT and MRI for Targeted Prostate Biopsy | Biotech Hunter | Biotech Hunter